The veterinary platform of NanoDetection Technology™ (NDT), is built on a scalable biochip-based diagnostic ecosystem designed to deliver rapid, highly sensitive detection of infectious and zoonotic diseases across multiple animal species. Leveraging the company's proprietary Luminorix™ Biochip instrument platform, each veterinary assay is developed on a common technology foundation, enabling efficient expansion of the test menu without major hardware modifications.

Current development programs include essays for Bovine Tuberculosis (bTB), Highly Pathogenic Avian Influenza (HPIA), Equine Infectious Anemia (EIA), African Swine Fever  (ASF), Classical Swine Fever (CSF), supporting applications in livestock health, food security, and zoonotic disease surveillance.  By combining quantitative detection, automation, and a flexible assay architecture, NDT’s veterinary platform aims to provide veterinarians, livestock producers, and animal health laboratories with rapid, laboratory-quality diagnostic results that improve disease management, biosecurity, and outbreak response capabilities.